Published 2025-08-09
license
Artículos

Description of billing guidelines for blood-derived products for medical account charges

DOI: https://doi.org/10.22490/ECISA.9946
Claudia Angelica Dazza Pineda Universidad Nacional Abierta y a Distancia
Jhonn Brauny Garcés Cabal Universidad Nacional Abierta y a Distancia

Transfusion therapy, one of the greatest achievements of modern medicine, has helped reduce mortality and extend and improve the quality of life for many people with various disorders. The administration of blood components is part of healthcare. The decision to transfuse a patient can sometimes be a difficult judgment, and physicians must base it on a careful evaluation of several factors and clinical signs. However, inappropriate use of blood and its components still exists today.

This document describes the billing guidelines for charging transfusions in hospitalized patients and/or those receiving outpatient care. It should be noted that, although the main characteristics of blood and its components, as well as general guidelines for their use, are described, this is not intended to serve as a guide for decision-making when indicating a transfusion, as this remains the exclusive responsibility of the attending physician.

keywords: Transfusion therapy, Blood components, Billing guidelines, Blood banks, blood products, Transfusion indication criteria
license

How to Cite

Dazza Pineda, C. A., & Garcés Cabal, J. B. (2025). Description of billing guidelines for blood-derived products for medical account charges. Documentos De Trabajo ECISA, 7. https://doi.org/10.22490/ECISA.9946
Metrics
Metrics Loading ...

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Design and implemented by